Charles Schwab Investment Management Inc. Purchases 28,145 Shares of HealthEquity, Inc. $HQY

Charles Schwab Investment Management Inc. increased its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 2.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,129,115 shares of the company’s stock after acquiring an additional 28,145 shares during the period. Charles Schwab Investment Management Inc. owned about 1.31% of HealthEquity worth $118,286,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of HQY. Price T Rowe Associates Inc. MD raised its stake in shares of HealthEquity by 995.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company’s stock worth $56,500,000 after purchasing an additional 580,988 shares during the period. Banco Bilbao Vizcaya Argentaria S.A. bought a new position in HealthEquity during the second quarter valued at about $492,000. Westfield Capital Management Co. LP increased its holdings in HealthEquity by 124.6% during the second quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock worth $132,543,000 after buying an additional 701,819 shares during the last quarter. Ashford Capital Management Inc. increased its holdings in HealthEquity by 2.1% during the first quarter. Ashford Capital Management Inc. now owns 274,999 shares of the company’s stock worth $24,302,000 after buying an additional 5,687 shares during the last quarter. Finally, Comerica Bank raised its position in HealthEquity by 43.4% in the first quarter. Comerica Bank now owns 70,153 shares of the company’s stock worth $6,199,000 after acquiring an additional 21,238 shares during the period. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Price Performance

HealthEquity stock opened at $104.99 on Friday. The firm has a market capitalization of $9.05 billion, a P/E ratio of 63.63, a PEG ratio of 1.36 and a beta of 0.47. HealthEquity, Inc. has a one year low of $74.07 and a one year high of $116.65. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23. The business has a fifty day moving average price of $95.89 and a 200-day moving average price of $96.78.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, September 2nd. The company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.92. HealthEquity had a return on equity of 12.04% and a net margin of 11.49%.The company had revenue of $325.80 million for the quarter, compared to analyst estimates of $320.68 million. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. As a group, equities research analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insider Buying and Selling

In other HealthEquity news, EVP Delano Ladd sold 6,000 shares of the stock in a transaction that occurred on Friday, September 19th. The shares were sold at an average price of $94.11, for a total value of $564,660.00. Following the sale, the executive vice president directly owned 79,456 shares in the company, valued at $7,477,604.16. This represents a 7.02% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the transaction, the executive vice president owned 49,795 shares of the company’s stock, valued at $4,392,416.95. This trade represents a 3.45% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 10,781 shares of company stock valued at $1,016,707 over the last 90 days. 1.50% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

HQY has been the subject of several research analyst reports. Barrington Research restated an “outperform” rating and set a $125.00 price target on shares of HealthEquity in a research note on Friday, August 29th. BMO Capital Markets initiated coverage on HealthEquity in a report on Thursday, November 13th. They set a “market perform” rating and a $100.00 price objective for the company. KeyCorp lowered their target price on HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 8th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. Finally, Royal Bank Of Canada lifted their price objective on HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, September 3rd. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $119.00.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.